ProBiotix Health Plc (OFEX: PBX)
Health Care · Biotechnology · GB
£0.10
+2.63% today · +25.8% 1Y
ProBiotix Health Plc (OFEX: PBX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $20.57M.
Over the last twelve months the share price has gained 25.8%.
Tweenvest scores ProBiotix Health Plc across four factors: quality 49/100, value 39/100, growth 100/100. Its strongest factor is growth.
PBX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $20.57M
- Revenue (TTM)
- $3.68M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 0.02
- 52-week high
- £—
- 52-week low
- £—
- Avg volume (3M)
- —
- Shares outstanding
- 158.17M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Nanollose LimitedASX: NC6 | $21.63M | AU$0.08 | -1.30% |
| Helyx Industries S.p.A.BIT: HLX | $20.77M | €0.70 | -7.67% |
| SkinBioTherapeutics plcAIM: SBTX | $20.74M | £0.06 | +12.15% |
| APTOCROM Inc.KOSDAQ: A109960 | $20.66M | ₩1,821.00 | -5.50% |
| Taiwan Advance Bio-Pharmaceutical Inc.TPEX: 4186 | $20.25M | NT$7.30 | -3.31% |
| BCAL Diagnostics LimitedASX: BDX | $20.15M | AU$0.08 | -12.22% |
| MDxHealth SANasdaqCM: MDXH | $19.71M | $0.21 | -64.97% |
| Modalis Therapeutics CorporationTSE: 4883 | $19.56M | ¥29.00 | -3.33% |
Figures last refreshed Oct 18, 2026.